Clinical trial
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
NCT00003600 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00003600 |
|---|---|
| Title | Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy |
| Official title | A Phase III Randomized Double-Blind Study of Erythropoietin Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia, Breast Cancer, Chronic Myeloproliferative Disorders, Drug/Agent Toxicity by Tissue/Organ, Leukemia, Lung Cancer, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Precancerous Condition, Small Intestine Cancer and 2 more |
| Intervention type | Biological, Other |
| Interventions | epoetin alfa, placebo |
| Enrollment | 344 |
| Start date | Dec 1, 1998 |
| Primary completion | Dec 1, 2001 |
| Completion | Jan 1, 2010 |
| First posted | Feb 20, 2004 |
| Last update posted | Jul 13, 2016 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: